Olr672 inhibitors represent a unique class of chemical compounds that specifically interact with and inhibit the activity of the Olr672 protein, a member of the olfactory receptor family. These receptors are G-protein coupled receptors (GPCRs) involved in the detection of odor molecules, playing a crucial role in the sense of smell. The Olr672 protein is encoded by the Olr672 gene, which belongs to a vast gene family that is highly diverse and species-specific. Olr672 inhibitors are designed to bind to the active site or allosteric sites of the Olr672 receptor, thereby modulating its function. These inhibitors can provide insights into the molecular mechanisms of olfactory reception and the signal transduction pathways activated by the binding of odorant molecules.
The study of Olr672 inhibitors also contributes significantly to the broader field of chemosensory research. By elucidating how these inhibitors affect Olr672 function, researchers can gain a deeper understanding of the structural and functional diversity of olfactory receptors. This knowledge is essential for mapping out the complex interactions between various odorants and their corresponding receptors. Furthermore, Olr672 inhibitors can serve as molecular tools in dissecting the signaling pathways downstream of olfactory receptors, which are often shared with other GPCRs. This can reveal novel aspects of GPCR regulation and function, potentially leading to new insights into the biochemistry of sensory perception. In addition to their role in basic research, Olr672 inhibitors also offer a framework for studying the evolution of the olfactory system across different species, given the substantial variability and specificity observed in olfactory receptor gene families.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Bruton's tyrosine kinase inhibitor, potentially impacting proteins in B-cell receptor signaling pathways. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Inhibits cyclin-dependent kinases 4 and 6, potentially affecting cell cycle-related proteins. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Inhibits multiple kinases, potentially disrupting proteins in cell signaling and growth pathways. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $118.00 $337.00 $520.00 $832.00 $1632.00 | 10 | |
BCL-2 inhibitor, potentially influencing apoptosis-related proteins. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Inhibits EGFR tyrosine kinase, potentially affecting proteins in the EGFR signaling pathway. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, potentially affecting protein degradation and cell cycle regulation. | ||||||